Protalix BioTherapeutics, Inc. Stock TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
TEL AVIV STOCK EXCHANGE
11:24:48 2023-03-21 am EDT
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| Market Cap | 215M 0 185M 175M 159M 297M 20.57B 300M 2.08B 800M 10.43B 808M 790M 33.14B | P/E 2026 * |
11.1x | P/E 2027 * | 53.4x |
|---|---|---|---|---|---|
| Enterprise Value | 215M 0 185M 175M 159M 297M 20.57B 300M 2.08B 800M 10.43B 808M 790M 33.14B | EV / Sales 2026 * |
2.62x | EV / Sales 2027 * | 3.24x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 215M | |
| +0.19% | -2.94% | +49.15% | +88.99% | 1,002B | |
| -0.29% | -4.35% | +51.50% | +63.73% | 644B | |
| +0.42% | -3.17% | +19.06% | +69.06% | 443B | |
| -0.63% | -3.09% | +29.84% | +36.08% | 343B | |
| +0.43% | -14.61% | +11.32% | +26.98% | 262B | |
| +0.93% | -3.19% | -1.31% | +11.96% | 245B | |
| -2.43% | -13.93% | +37.25% | +46.05% | 212B | |
| -0.90% | -5.06% | -18.47% | -58.14% | 199B | |
| -0.82% | -4.52% | +25.28% | +87.42% | 181B | |
| Average | -0.18% | -5.00% | +22.62% | +41.35% | 392.19B | |
| Weighted average by Cap. | -0.06% | -4.24% | +31.87% | +55.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 82.16M 0 70.66M 66.67M 60.73M 114M 7.85B 115M 794M 306M 3.98B 309M 302M 12.65B | 66.48M 0 57.17M 53.94M 49.14M 91.87M 6.36B 92.7M 642M 247M 3.22B 250M 244M 10.24B |
| Net income | 19.63M 0 16.88M 15.93M 14.51M 27.13M 1.88B 27.37M 190M 73.02M 952M 73.72M 72.11M 3.02B | 3.79M 0 3.26M 3.08M 2.8M 5.24M 363M 5.29M 36.66M 14.11M 184M 14.25M 13.94M 584M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
